in high dose females , significantly decreased incidences of mammary fibroadenomas , pituitary chromophobe adenomas , and thyroid parafollicular cell tumors ( p less than 0.01 ) contributed to an overall decrease in both benign tumors and in the combined benign and malignant tumor rates .
C0027651
tumors
C0006826
malignant tumor